Friday, November 22nd, 2024

Corporate news summary

ThaiBev Reports 2.2% Revenue Growth and 0.6% Net Profit Increase in FY2024 Financial Results
The company declared a final dividend of Baht 0.47 per share, with a total dividend for the year of Baht 0.62 per share

BRC Asia Achieves Record S$93.5M Profit in FY2024, Declares 14 Cents Dividend

TSH Resources Announces 2.5 Sen Interim Dividend for FY2024 – Key Dates for Shareholders

HG Metal Manufacturing’s Strategic Rights Issue: A Game Changer for Growth
HG Metal has confirmed receiving approval in-principle for a proposed renounceable non-underwritten rights issue, potentially affecting up to 74,254,237 new ordinary shares at S\$0.266 each.

This rights issue allows existing shareholders to acquire additional shares on the basis of 10 Rights Shares for every 27 existing shares, thus offering them a chance to increase their stake in the company and partake in its anticipated growth.

Boustead Real Estate Division Secures MYR300M Data Centre Contract in Malaysia, Boosting Order Backlog

17LIVE’s Strategic Moves: Share Buybacks and ESOP Amendments Aim to Boost Shareholder Value

Nanofilm’s Aggressive Global Expansion: Can New Customers and Emerging Markets Offset China Dependence?

Nanofilm Technologies Reports Robust 3Q2024 Performance, Announces Strategic Global Expansions Nanofilm Technologies Reports Robust 3Q2024 Performance, Announces Strategic Global Expansions Nanofilm Technologies International Limited, a leading provider of nanotechnology solutions, has reported strong financial...

NikkoAM-StraitsTrading Asia ex Japan REIT ETF – Dividend Distribution for the Period May 1, 2024 to July 31, 2024

Key facts for investors: Dividend Announcement: Nikko Asset Management Asia Limited announced a dividend distribution of S$0.0111 per unit for the period from May 1, 2024, to July 31, 2024. Record Date: The dividend...

Hyphens Pharma Defies Odds: 32.6% Profit Surge Despite Challenging Quarter

Hyphens Pharma Posts Strong Revenue Growth in 9M2024 Despite Rising Costs Hyphens Pharma Posts Strong Revenue Growth in 9M2024 Despite Rising Costs Hyphens Pharma International Limited, along with its subsidiaries, has reported an impressive...